These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 32646926)

  • 41. The faecal immunochemical test in low risk patients with suspected bowel cancer.
    D'Souza N; Abulafi M
    Br J Hosp Med (Lond); 2019 Jan; 80(1):22-26. PubMed ID: 30592674
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quantitative FIT stratification is superior to NICE referral criteria NG12 in a high-risk colorectal cancer population.
    Bailey JA; Ibrahim H; Bunce J; Chapman CJ; Morling JR; Simpson JA; Humes DJ; Banerjea A
    Tech Coloproctol; 2021 Oct; 25(10):1151-1154. PubMed ID: 34263362
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Application of NICE guideline NG12 to the initial assessment of patients with lower gastrointestinal symptoms: not FIT for purpose?
    Quyn AJ; Steele RJ; Digby J; Strachan JA; Mowat C; McDonald PJ; Carey FA; Godber IM; Younes HB; Fraser CG
    Ann Clin Biochem; 2018 Jan; 55(1):69-76. PubMed ID: 28661203
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of the faecal immunochemical test in patients with risk-stratified suspected colorectal cancer symptoms: A systematic review and meta-analysis to inform the ACPGBI/BSG guidelines.
    Booth R; Carten R; D'Souza N; Westwood M; Kleijnen J; Abulafi M
    Lancet Reg Health Eur; 2022 Dec; 23():100518. PubMed ID: 36212984
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The fecal hemoglobin concentration, age and sex test score: Development and external validation of a simple prediction tool for colorectal cancer detection in symptomatic patients.
    Cubiella J; Digby J; Rodríguez-Alonso L; Vega P; Salve M; Díaz-Ondina M; Strachan JA; Mowat C; McDonald PJ; Carey FA; Godber IM; Younes HB; Rodriguez-Moranta F; Quintero E; Álvarez-Sánchez V; Fernández-Bañares F; Boadas J; Campo R; Bujanda L; Garayoa A; Ferrandez Á; Piñol V; Rodríguez-Alcalde D; Guardiola J; Steele RJ; Fraser CG;
    Int J Cancer; 2017 May; 140(10):2201-2211. PubMed ID: 28187494
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tests and investigations for colorectal cancer screening.
    Carroll MR; Seaman HE; Halloran SP
    Clin Biochem; 2014 Jul; 47(10-11):921-39. PubMed ID: 24769265
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Potential roles of artificial intelligence learning and faecal immunochemical testing for prioritisation of colonoscopy in anaemia.
    Ayling RM; Lewis SJ; Cotter F
    Br J Haematol; 2019 Apr; 185(2):311-316. PubMed ID: 30714125
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diagnostic performance of a faecal immunochemical test for patients with low-risk symptoms of colorectal cancer in primary care: an evaluation in the South West of England.
    Bailey SER; Abel GA; Atkins A; Byford R; Davies SJ; Mays J; McDonald TJ; Miller J; Neck C; Renninson J; Thomas P; Walter FM; Warren S; Hamilton W
    Br J Cancer; 2021 Mar; 124(7):1231-1236. PubMed ID: 33462361
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diagnostic accuracy of point of care faecal immunochemical testing using a portable high-speed quantitative analyser for diagnosis in 2-week wait patients.
    Maclean W; Mackenzie P; Limb C; Zahoor Z; Whyte MB; Rockall T; Benton SC; Jourdan I
    Colorectal Dis; 2021 Sep; 23(9):2376-2386. PubMed ID: 34157205
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diagnostic inconsistency of faecal immunochemical tests for haemoglobin in population screening of colorectal cancer.
    Huang Y; Ge W; London V; Li Q; Cai S; Zhang S; Zheng S
    Clin Chem Lab Med; 2013 Nov; 51(11):2173-80. PubMed ID: 24145058
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Faecal haemoglobin concentration among subjects with negative FIT results is associated with the detection rate of neoplasia at subsequent rounds: a prospective study in the context of population based screening programmes in Italy.
    Senore C; Zappa M; Campari C; Crotta S; Armaroli P; Arrigoni A; Cassoni P; Colla R; Fracchia M; Gili F; Grazzini G; Lolli R; Menozzi P; Orione L; Polizzi S; Rapi S; Riggi E; Rubeca T; Sassatelli R; Visioli C; Segnan N
    Gut; 2020 Mar; 69(3):523-530. PubMed ID: 31455608
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An evaluation of the SENTiFIT 270 analyser for quantitation of faecal haemoglobin in the investigation of patients with suspected colorectal cancer.
    Auge JM; Rodriguez C; Espanyol O; Rivero L; Sandalinas S; Grau J; Jimenez W; Castells A
    Clin Chem Lab Med; 2018 Mar; 56(4):625-633. PubMed ID: 29150989
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Faecal immunochemical testing for haemoglobin in detecting bowel polyps in symptomatic patients: multicentre prospective cohort study.
    Bath MF; Malhi A; Ayling RM; Seward E; Pritchard-Jones K; Laszlo HE; Hackshaw A; Machesney MR
    BJS Open; 2023 Mar; 7(2):. PubMed ID: 36884345
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Are hemoglobin levels really lower in faecal immunochemical test positive patients with colorectal cancer?
    Ng JY; Tan IJ; Tan KK
    Surgeon; 2018 Feb; 16(1):36-39. PubMed ID: 28108269
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Performance of two faecal immunochemical tests for the detection of advanced neoplasia at different positivity thresholds: a cross-sectional study of the Dutch national colorectal cancer screening programme.
    de Klerk CM; Wieten E; Lansdorp-Vogelaar I; Bossuyt PM; Spaander MC; Dekker E
    Lancet Gastroenterol Hepatol; 2019 Feb; 4(2):111-118. PubMed ID: 30497962
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Faecal haemoglobin concentration influences risk prediction of interval cancers resulting from inadequate colonoscopy quality: analysis of the Taiwanese Nationwide Colorectal Cancer Screening Program.
    Chiu SY; Chuang SL; Chen SL; Yen AM; Fann JC; Chang DC; Lee YC; Wu MS; Chou CK; Hsu WF; Chiou ST; Chiu HM
    Gut; 2017 Feb; 66(2):293-300. PubMed ID: 26515543
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diagnostic Accuracy of a Qualitative Fecal Immunochemical Test Varies With Location of Neoplasia But Not Number of Specimens.
    Wong MC; Ching JY; Chan VC; Lam TY; Shum JP; Luk AK; Wong SS; Ng SC; Ng SS; Wu JC; Chan FK; Sung JJ
    Clin Gastroenterol Hepatol; 2015 Aug; 13(8):1472-9. PubMed ID: 25724708
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term performance of colorectal cancerscreening programmes based on the faecal immunochemical test.
    Zorzi M; Hassan C; Capodaglio G; Fedato C; Montaguti A; Turrin A; Rosano A; Monetti D; Stocco C; Baracco S; Russo F; Repici A; Rugge M
    Gut; 2018 Dec; 67(12):2124-2130. PubMed ID: 29101260
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multiple rounds of one sample versus two sample faecal immunochemical test-based colorectal cancer screening: a population-based study.
    Schreuders EH; Grobbee EJ; Nieuwenburg SAV; Kapidzic A; van Roon AHC; van Vuuren AJ; Lansdorp-Vogelaar I; Spijker WWJ; Izelaar K; Bruno MJ; Kuipers EJ; Spaander MCW
    Lancet Gastroenterol Hepatol; 2019 Aug; 4(8):622-631. PubMed ID: 31196734
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunochemical faecal occult blood testing to screen for colorectal cancer: can the screening interval be extended?
    Haug U; Grobbee EJ; Lansdorp-Vogelaar I; Spaander MCW; Kuipers EJ
    Gut; 2017 Jul; 66(7):1262-1267. PubMed ID: 27006184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.